Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


Clinical Trial of the Use of Ketamine in Treatment Resistant Depression


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT02610712

Organisation Name: National Institute of Neurology and Neurosurgery, Mexico

Overal Status: Unknown status

Start Date: May 2014

Last Update: September 21, 2016

Lead Sponsor: National Institute of Neurology and Neurosurgery, Mexico

Brief Summary: The purpose of this study is to determine the efficacy of the use of intravenous low-dose ketamine in the treatment of treatment-resistant depression (TRD), as well as the changes in Glutamate neurotransmission and inflammatory serum markers.

Conditions:
  • Depressive Disorder, Treatment-Resistant


Total execution time in seconds: 0.14938616752625